Global gene expression profiling in R155H knock-in murine model of VCP disease.
Global gene expression profiling in R155H knock-in murine model of VCP disease.
复制标题
DOI:
10.1111/cts.12241
复制
发表时间:
2015-02
期刊:
影响因子:
--
通讯作者:
Kimonis VE
中科院分区:
文献类型:
--
作者:
Nalbandian A;Ghimbovschi S;Wang Z;Knoblach S;Llewellyn KJ;Vesa J;Hoffman EP;Kimonis VE
Dominant mutations in the valosin containing protein (VCP) gene cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia (IBMPFD), which is characterized by progressive muscle weakness, dysfunction in bone remodeling, and frontotemporal dementia. More recently, VCP has been linked to 2% of familial amyotrophic lateral sclerosis (ALS) cases. VCP plays a significant role in a plethora of cellular functions including membrane fusion, transcription activation, nuclear envelope reconstruction, post-mitotic organelle reassembly, cell cycle control. To elucidate the pathological mechanisms underlying the VCP disease progression, we have previously generated a VCPR155H/+ mouse model with the R155H mutation. Histological analyses of mutant muscle showed vacuolization of myofibrils, centrally located nuclei, and disorganized muscle fibers. Global expression profiling of VCPR155H/+ mice using gene annotations by DAVID identified key dysregulated signaling pathways including genes involved in the physiological system development and function, diseases and disorders, and molecular and cellular functions. There were a total of 212 significantly dysregulated genes, several of which are involved in the regulation of proteasomal function and NF-κB signaling cascade. Findings of the gene expression study were validated by using quantitative reverse transcriptase polymerase chain reaction analyses to test genes involved in various signaling cascades. This investigation reveals the importance of the VCPR155H/+ mouse model in the understanding of cellular and molecular mechanisms causing VCP-associated neurodegenerative diseases and in the discovery of novel therapeutic advancements and strategies for patients suffering with these debilitating disorders.
登录
查看更多内容
DOI:
10.1111/j.1752-8062.2012.00407.x
发表时间:
2012-06
期刊:
Clinical and translational science
影响因子:
--
作者:
Nalbandian A;Ghimbovschi S;Radom-Aizik S;Dec E;Vesa J;Martin B;Knoblach S;Smith C;Hoffman E;Kimonis VE
通讯作者:
Kimonis VE
影响因子:
7.8
作者:
Fu, Xinrong;Ng, Christine;Feng, Daorong;Liang, Chun
通讯作者:
Liang, Chun
影响因子:
4.8
作者:
Müller, JMM;Meyer, HH;Shima, DT
通讯作者:
Shima, DT
DOI:
10.1196/annals.1396.020
发表时间:
2007-01-01
期刊:
HEALTHY AGING AND LONGEVITY
影响因子:
--
作者:
Bergamini, Ettore;Cavallini, Gabriella;Gori, Zina
通讯作者:
Gori, Zina
DOI:
10.1083/jcb.114.3.443
发表时间:
1991-08
期刊:
The Journal of cell biology
影响因子:
--
作者:
Fröhlich KU;Fries HW;Rüdiger M;Erdmann R;Botstein D;Mecke D
通讯作者:
Mecke D